Company profile · free preview

SOPHiA GENETICS S.A.

SOPH · NASDAQ · Healthcare · Updated 11/18/2026

Five-year financials

Fiscal year
Revenue
Net income
Diluted EPS
Operating cash flow
Free cash flow
Cash
Total debt

Financials are being prepared.

Want the story behind these numbers? Ask Osiris anything about SOPHiA GENETICS S.A.'s filings — free.

Create free account

SOPHiA GENETICS S.A. return on capital (fiscal 2025)

ROIC

—

Return on capital

—

Return on equity

-110.0%

Return on assets

-49.6%

Gross margin

67.4%

Operating margin

-91.8%

Net debt / EBITDA

0.37x

SOPHiA GENETICS S.A. insider buying and selling

Recent open-market trades reported on Form 4. Context only — not a reason to buy or sell.

DateInsiderTypeSharesPrice
2026-11-06Muken RossPurchase20,000$6.86
2026-11-06CARDOZA GEORGEPurchase20,000$7.06
2026-10-13Xu ZhenyuSale4,000$7.18
2026-10-12Menu PhilippeSale5,000$7.26
2026-10-12Camblong JurgiSale8,500$7.26
2026-10-05Van Well DaanSale6,168$8.12
2026-10-05Valente ManuelaSale4,240$8.13
2026-10-05Verma AbhimanyuSale5,284$8.12

SEC filings

No filings stored yet.

Ask anything about SOPHiA GENETICS S.A.'s filings

"What changed since last year?" "Where is the cash going?" Get answers drawn straight from the filings.

Start researching free

Compare SOPH head-to-head

More Healthcare companies